As IL-6 levels were investigated in the acute phase (<8 h) post-stroke in the present study and IL-6 is known to peak after 24 h (43), this suggests that IL-6 is not a reliable biomarker in the acute phase after stroke debut. This evidence concerns the gene IL6 and Stroke.